Medical Condition News

RSS

Ampio awarded composition of matter patent for Ampion in Europe

Ampio Pharmaceuticals, Inc., a company that discovers and develops new uses for previously approved drugs and new molecular entities, today announced receipt of notification of the granting of a European patent with broad claims directed to compositions containing DA-DKP, a cyclic dipeptide diketopiperazine which is the active ingredient of Ampion™.

7 Dec 2011

Racial differences in inflammation might explain survival paradox among dialysis patients

In the general population, African Americans die at earlier ages than whites, but among patients on dialysis, African Americans live longer than whites. A new study helps explain this paradox and could help prolong the lives of all patients on dialysis.

7 Dec 2011

Relaxin improves poor blood flow and kidney function in a rat model of PKD

After a four-week course of the vasodilator hormone relaxin, kidney function and blood flow immediately improved in lab rats genetically altered to model polycystic kidney disease (PKD), a life-threatening genetic disorder, according to research presented on Dec. 6 at the American Society for Cell Biology Annual Meeting in Denver.

7 Dec 2011

Diabetes increases risk of emergency caesarean birth in women with poorly contracting uterus

Researchers at the University of Liverpool have found that the strength of uterine contractions in diabetic pregnant women is significantly weaker than in non-diabetic women, increasing the risk of emergency caesarean birth.

7 Dec 2011

Aethlon receives approval to begin Hemopurifier study at Sarcoma Oncology Center

Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that a cancer research study to test the ex vivo effectiveness of the Aethlon Hemopurifier to capture tumor-secreted exosomes from the blood of advanced-stage cancer patients has received institutional review board approval to begin studies at the Sarcoma Oncology Center, based in Santa Monica, California.

7 Dec 2011

Headache affects one of every two HIV/AIDS patients

A University of Mississippi study of headaches among HIV patients is being hailed as a critical step to improving treatment and reducing unnecessary medical costs among sufferers.

7 Dec 2011

AFECTAIR may be an effective alternative to SoC for delivery of inhaled nitric oxide

Discovery Laboratories, Inc. today released new data showing that use of AFECTAIR resulted in as much as a 70 percent reduction in the amount of nitric oxide required to deliver the desired dose of the therapeutic gas when compared with current standard of care.

7 Dec 2011

ZIOPHARM receives European patent allowance for palifosfamide to treat cancer

ZIOPHARM Oncology, Inc. announced today that it has received an allowance from the European Patent Office for Patent Application No. 05 821 125.1, entitled "Salts of Isophosphoramide mustard and analogs thereof as anti-tumor agents" with claims directed to pharmaceutical compositions of a novel DNA cross-linker, including palifosfamide and their use in treating cancer.

7 Dec 2011

True impact of injuries in the UK higher than previously thought

Injuries in the UK are having a much greater impact on peoples' lives than previously estimated, a study has found.

7 Dec 2011

Researchers identify likely cause of essential tremor

Researchers from the CHUQ research center and Universit- Laval have discovered the likely cause of essential tremor (ET), a neurological disorder that affects more than 10 million North Americans.

7 Dec 2011

New NHGRI funding plan sharpens focus of Genome Sequencing Program on medical apps

A new funding plan by the National Human Genome Research Institute (NHGRI) sharpens the focus of its flagship Genome Sequencing Program on medical applications. In addition to continuing on-going studies, the four-year, $416 million plan launches new efforts to find causes of rare inherited diseases and accelerate the use of genome sequence information in the medical care of patients.

7 Dec 2011

Future of drug discovery and development to be highlighted at 2011 BPS Winter Meeting

The future of drug discovery and development at the bench and in the boardroom will be highlighted at a major international pharmacology conference in London, Tuesday 13 to Thursday 15 December.

7 Dec 2011

Web-based video game players contribute to analysis of DNA sequences

Thousands of video game players have helped significantly advance our understanding of the genetic basis of diseases such as Alzheimer's, diabetes and cancer over the past year. They are the users of a web-based video game developed by Dr. J-r-me Waldispuhl of the McGill School of Computer Science and collaborator Mathieu Blanchette.

7 Dec 2011

King's College London submits first clinical grade xeno-free hES cell lines to the UKSCB

Stem cell scientists at King's College London will announce they have submitted to the UK Stem Cell Bank (UKSCB) their first clinical grade human embryonic stem (hES) cell lines that are free from animal-derived products, known as 'xeno-free' stem cells.

7 Dec 2011

SG Austria, Nuvilex use live cell encapsulation technology and treat diabetes in animal model

Nuvilex, Inc. announced today their affiliate SG Austria and partners have successfully treated diabetes in an established, recognized animal model utilizing live encapsulated cells.

7 Dec 2011

Combination of cannabinoids and opiates could help reduce chronic pain

A UCSF study suggests patients with chronic pain may experience greater relief if their doctors add cannabinoids - the main ingredient in cannabis or medical marijuana - to an opiates-only treatment. The findings, from a small-scale study, also suggest that a combined therapy could result in reduced opiate dosages.

7 Dec 2011

Pretreatment fasting glucose could block breast cancer progression

An increasing understanding of molecular pathways that regulate breast and colorectal cancer development and progression has produced new therapeutic agents, including the biologic agents trastuzumab, bevacizumab, and cetuximab. Identifying the indicators that are likely to predict which patients will achieve the best response to these agents represents a major challenge for contemporary oncologists.

7 Dec 2011

UCSF resident to receive 2012 William P. Van Wagenen Fellowship

The William P. Van Wagenen Fellowship Selection Committee has announced Matthew Christopher Tate, MD, as the recipient of the 2012 William P. Van Wagenen Fellowship. Dr. Tate, a resident in neurological surgery at University of California in San Francisco, will commence the fellowship on July 1, 2012.

7 Dec 2011

Health Alliance, Bayer sign outcomes-based contract to support MS patients

Bayer HealthCare and Health Alliance Medical Plans have entered into an outcomes-based contract for people with relapsing-remitting multiple sclerosis (MS) who are taking Betaseron (interferon beta-1b) to reduce the frequency of clinical exacerbations.

7 Dec 2011

Biologists discover how fruit flies can provide solutions to human pain, control insect-borne diseases

Studies of a protein that fruit flies use to sense heat and chemicals may someday provide solutions to human pain and the control of disease-spreading mosquitoes.

7 Dec 2011

Medical Condition News

Ampio awarded composition of matter patent for Ampion in Europe

Racial differences in inflammation might explain survival paradox among dialysis patients

Relaxin improves poor blood flow and kidney function in a rat model of PKD

Diabetes increases risk of emergency caesarean birth in women with poorly contracting uterus

Aethlon receives approval to begin Hemopurifier study at Sarcoma Oncology Center

Headache affects one of every two HIV/AIDS patients

AFECTAIR may be an effective alternative to SoC for delivery of inhaled nitric oxide

ZIOPHARM receives European patent allowance for palifosfamide to treat cancer

True impact of injuries in the UK higher than previously thought

Researchers identify likely cause of essential tremor

New NHGRI funding plan sharpens focus of Genome Sequencing Program on medical apps

Future of drug discovery and development to be highlighted at 2011 BPS Winter Meeting

Web-based video game players contribute to analysis of DNA sequences

King's College London submits first clinical grade xeno-free hES cell lines to the UKSCB

SG Austria, Nuvilex use live cell encapsulation technology and treat diabetes in animal model

Combination of cannabinoids and opiates could help reduce chronic pain

Pretreatment fasting glucose could block breast cancer progression

UCSF resident to receive 2012 William P. Van Wagenen Fellowship

Health Alliance, Bayer sign outcomes-based contract to support MS patients

Biologists discover how fruit flies can provide solutions to human pain, control insect-borne diseases

This International Women’s Day, Meet the Scientist Changing Women’s Healthcare

Microphysiological systems in drug discovery

Considerations for taking ASO discovery programs into animal models

Latest News